TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) has issued an announcement.
Shanghai MicroPort MedBot (Group) Co., Ltd. held its 2025 Extraordinary General Meeting (EGM) on November 25, 2025, where several key resolutions were passed. These included the appointment of new directors and amendments to the Articles of Association and Rules of Procedure, reflecting the company’s strategic direction and governance enhancements. The successful passing of these resolutions indicates a strong shareholder support and positions the company for future growth and operational efficiency.
The most recent analyst rating on (HK:2252) stock is a Sell with a HK$20.00 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. is a joint stock company incorporated in China, focusing on the medical technology industry. The company is involved in the development and production of advanced medical devices and robotics, aiming to enhance healthcare delivery and patient outcomes.
Average Trading Volume: 5,962,532
Technical Sentiment Signal: Buy
Current Market Cap: HK$22.42B
For detailed information about 2252 stock, go to TipRanks’ Stock Analysis page.